Brian Wattenberg, Ph.D.
Massey Cancer Center research program membership
Department of Biochemistry and Molecular Biology,
School of Medicine
PhD, Washington University (1981)
We are studying the regulation of a class of lipids known as sphingolipids. Many sphingolipids are known to have critical roles in tumorogenic process either in the promotion of the process or in tumor suppression. Our hope is that by understanding the molecular mechanisms by which sphingolipid metabolism is controlled, both in normal and tumor cells, we will be able to design strategies to improve treatment of cancer.
Disease focus of research
Apoptosis,Autophagy,Cancer cell biology,Cancer therapy resistance,Cell signaling,Lipid signaling
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed